Form follows function: Lymphoid tissue microarchitecture in antimicrobial immune defence

Nature Reviews Immunology

Volumn 8, Issue 10, 2008, Pages 764-775

  Junt, Tobias ^a   Scandella, Elke ^b   Ludewig, Burkhard ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR5; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERFERON; INTERLEUKIN 7; LYMPHOTOXIN BETA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; SCLEROPROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; SPHINGOSINE 1 PHOSPHATE; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ANTIMICROBIAL ACTIVITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW; BRUCELLA ABORTUS; CELL AGGREGATION; CELL MIGRATION; CELL SPECIFICITY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOWN REGULATION; EFFECTOR CELL; GENE TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LACTOBACILLUS; LYMPH FOLLICLE; LYMPH NODE; LYMPHANGIOGENESIS; LYMPHOCYTE ACTIVATION; LYMPHOID ORGAN; LYMPHOID TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROENVIRONMENT; MOLECULAR WEIGHT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PEYER PATCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SPLEEN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; HUMANS; INFECTION; LYMPH NODES; LYMPHOID TISSUE; PEYER'S PATCHES; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 52949090785     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2414     Document Type: Review

References (115)

1. Sullivan, L. H. The tall office building artistically considered. Lippincott's Magazine [online] http://ecow.engr.wisc.edu/cgi-bin/get/cee/ 340/bank/interestin/formfollowsfunctionsullivan-189.pdf (1896).
2. Cose, S., Brammer, C., Khanna, K. M., Masopust, D. & Lefrancois, L. Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway. Eur. J. Immunol. 36, 1423-1433 (2006).
3. Feuerer, M. et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nature Med. 9, 1151-1157 (2003).
4. Cavanagh, L. L. et al. Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells. Nature Immunol. 6, 1029-1037 (2005).
5. Ochsenbein, A. F. et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286, 2156-2159 (1999).
6. + macrophages that line the SCS of lymph nodes as essential for the capture of viruses and the initiation of antiviral B-cell responses.
7. Cervantes-Barragan, L. et al. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109, 1131-1137 (2007).
8. Stoll, S., Delon, J., Brotz, T. M. & Germain, R. N. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296, 1873-1876 (2002).
9. Mempel, T. R., Henrickson, S. E. & von Andrian, U. H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154-159 (2004).
10. Schluns, K. S. & Lefrancois, L. Cytokine control of memory T-cell development and survival. Nature Rev. Immunol. 3, 269-279 (2003).
11. -/-) mutant mice. J. Exp. Med. 185, 2157-2170 (1997). This study shows that lymph nodes are crucial for the induction of antiviral immune responses. In the absence of lymph nodes, cytopathic virus infection resulted in death of the animals, whereas infection with a non-cytopathic virus led to viral persistence.
12. Junt, T. et al. Expression of lymphotoxin β governs immunity at two distinct levels. Eur. J. Immunol. 36, 2061-2075 (2006).
13. +-T-cell expansion and trafficking following central nervous system infection. J. Virol. 77, 2775-2778 (2003).
14. Blattman, J. N. et al. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195, 657-664 (2002).
15. + T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27, 203-213 (2007).
16. + T cells.
17. Gewurz, B. E., Gaudet, R., Tortorella, D., Wang, E. W. & Ploegh, H. L. Virus subversion of immunity: a structural perspective. Curr. Opin. Immunol. 13, 442-450 (2001).
18. Wertheim, H. F. et al. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med. 5, e17 (2008).
19. Eberl, G. From induced to programmed lymphoid tissues: the long road to preempt pathogens. Trends Immunol. 28, 423-428 (2007).
20. Soderberg, K. A. et al. Innate control of adaptive immunity via remodeling of lymph node feed arteriole. Proc. Natl Acad. Sci. USA 102, 16315-16320 (2005).
21. Angeli, V. et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24, 203-215 (2006).
22. Schwab, S. R. & Cyster, J. G. Finding a way out: lymphocyte egress from lymphoid organs. Nature Immunol. 8, 1295-1301 (2007).
23. Germain, R. N. et al. Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging. Immunol. Rev. 221, 163-181 (2008).
24. Sixt, M. et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22, 19-29 (2005). This study describes antigen sampling by lymph-node-resident DCs from within the FRC-conduit system.
25. Gretz, J. E., Norbury, C. C., Anderson, A. O., Proudfoot, A. E. & Shaw, S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192, 1425-1440 (2000).
26. Fenner, F. Mouse-pox; infectious ectromelia of mice; a review. J. Immunol. 63, 341-373 (1949).
27. Balazs, M., Martin, F., Zhou, T. & Kearney, J. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17, 341-352 (2002).
28. Ludewig, B. et al. Induction of optimal anti-viral neutralizing B cell responses by dendritic cells requires transport and release of virus particles in secondary lymphoid organs. Eur. J. Immunol. 30, 185-196 (2000).
29. Aichele, P. et al. Macrophages of the splenic marginal zone are essential for trapping of blood-borne particulate antigen but dispensable for induction of specific T cell responses. J. Immunol. 171, 1148-1155 (2003).
30. Han, Y., van Rooijen, N. & Cutler, J. E. Binding of Candida albicans yeast cells to mouse popliteal lymph node tissue is mediated by macrophages. Infect. Immun. 61, 3244-3249 (1993).
31. Buiting, A. M., De Rover, Z., Kraal, G. & van Rooijen, N. Humoral immune responses against particulate bacterial antigens are dependent on marginal metallophilic macrophages in the spleen. Scand. J. Immunol. 43, 398-405 (1996).
32. Manuelidis, L. et al. Follicular dendritic cells and dissemination of Creutzfeldt-Jakob disease. J. Virol. 74, 8614-8622 (2000).
33. Gorak, P. M., Engwerda, C. R. & Kaye, P. M. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur. J. Immunol. 28, 687-695 (1998).
34. Seiler, P. et al. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur. J. Immunol. 27, 2626-2633 (1997).
35. Crocker, P. R., Paulson, J. C. & Varki, A. Siglecs and their roles in the immune system. Nature Rev. Immunol. 7, 255-266 (2007).
36. Ochsenbein, A. F. & Zinkernagel, R. M. Natural antibodies and complement link innate and acquired immunity. Immunol. Today 21, 624-630 (2000).
37. Phan, T. G., Grigorova, I., Okada, T. & Cyster, J. G. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nature Immunol. 8, 992-1000 (2007).
38. Geijtenbeek, T. B. et al. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 100, 2908-2916 (2002).
39. Kang, Y. S. et al. The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc. Natl Acad. Sci. USA. 101, 215-220 (2004).
40. Kraal, G., van der Laan, L. J., Elomaa, O. & Tryggvason, K. The macrophage receptor MARCO. Microbes Infect. 2, 313-316 (2000).
41. Chen, Y. et al. Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A. J. Immunol. 175, 8173-8180 (2005).
42. Qi, H., Egen, J. G., Huang, A. Y. & Germain, R. N. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312, 1672-1676 (2006).
43. Muller, S. et al. Role of an intact splenic microarchitecture in early lymphocytic choriomeningitis virus production. J. Virol. 76, 2375-2383 (2002).
44. Eloranta, M. L. & Alm, G. V. Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-α/ β producers in mice upon intravenous challenge with herpes simplex virus. Scand. J. Immunol. 49, 391-394 (1999).
45. + T cells by exogenous cell-associated antigens. Immunity 17, 211-220 (2002).
46. - DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 141, 398-404 (2005).
47. Manolova, V. et al. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38, 1404-1413 (2008).
48. Macpherson, A. J. & Uhr, T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303, 1662-1665 (2004).
49. Itano, A. A. et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19, 47-57 (2003).
50. Katakai, T., Hara, T., Sugai, M., Gonda, H. & Shimizu, A. Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J. Exp. Med. 200, 783-795 (2004).
51. Farr, A. G. et al. Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues. J. Exp. Med. 176, 1477-1482 (1992).
52. Katakai, T. et al. A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int. Immunol. 16, 1133-1142 (2004).
53. Gretz, J. E., Anderson, A. O. & Shaw, S. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol. Rev. 156, 11-24 (1997).
54. Nolte, M. A. et al. A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp. J. Exp. Med. 198, 505-512 (2003). This study reveals that the conduit system in the spleen has an important role in the distribution of both blood-borne and locally produced molecules, and provides a framework for directing lymphocyte migration and the organization of the white pulp of the spleen.
55. Palframan, R. T. et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J. Exp. Med. 194, 1361-1373 (2001).
56. MartIn-Fontecha, A. et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198, 615-621 (2003).
57. Marsland, B. J. et al. CCL19 and CCL21 induce a potent proinflammatory differentiation program in licensed dendritic cells. Immunity 22, 493-505 (2005).
58. Webster, B. et al. Regulation of lymph node vascular growth by dendritic cells. J. Exp. Med. 203, 1903-1913 (2006).
59. Luther, S. A., Tang, H. L., Hyman, P. L., Farr, A. G. & Cyster, J. G. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl Acad. Sci. USA 97, 12694-12699 (2000).
60. Sallusto, F. et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769 (1998).
61. Forster, R., Davalos-Misslitz, A. C. & Rot, A. CCR7 and its ligands: balancing immunity and tolerance. Nature Rev. Immunol. 8, 362-371 (2008).
62. Woolf, E. et al. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces. Nature Immunol. 8, 1076-1085 (2007).
63. Baekkevold, E. S. et al. The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 193, 1105-1112 (2001).
64. Link, A. et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nature Immunol. 8, 1255-1265 (2007). This study reveals that access of T cells to IL-7-producing FRCs in lymph nodes is crucial for T-cell homeostasis.
65. + T cell-dendritic cell interaction. Nature 440, 890-895 (2006).
66. Bajenoff, M. et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25, 989-1001 (2006). This study shows that T cells are in continuous intimate contact with FRCs as they migrate through the T-cell zone and that FRCs delimit the borders of the T-cell zone.
67. Lee, J. W. et al. Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nature Immunol. 8, 181-190 (2007). This study reveals that peripheral tolerance can not only be mediated by DCs in SLOs that have taken up antigen in peripheral tissues but also by stromal cells in the lymph node, which synthesize and present peripheral tissue antigens directly to T cells.
68. Thomas, S., Kolumam, G. A. & Murali-Krishna, K. Antigen presentation by nonhemopoietic cells amplifies clonal expansion of effector CD8 T cells in a pathogen-specific manner. J. Immunol. 178, 5802-5811 (2007).
69. Jones, S., Horwood, N., Cope, A. & Dazzi, F. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J. Immunol. 179, 2824-2831 (2007).
70. Mueller, S. N. et al. Viral targeting of fibroblastic reticular cells contributes to immunosuppression and persistence during chronic infection. Proc. Natl Acad. Sci. USA 104, 15430-15435 (2007).
71. + progenitor cells.
72. Henrickson, S. E. et al. T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nature Immunol. 9, 282-291 (2008).
73. + T cell memory. Immunity 28, 258-270 (2008).
74. Tumanov, A. V. et al. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 195, 106-116 (2003).
75. Forster, R. et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037-1047 (1996).
76. Junt, T. et al. CXCR5-dependent seeding of follicular niches by B and Th cells augments antiviral B cell responses. J. Immunol. 175, 7109-7116 (2005).
77. Forster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33 (1999).
78. Junt, T. et al. Antiviral immune responses in the absence of organized lymphoid T cell zones in plt/plt mice. J. Immunol. 168, 6032-6040 (2002).
79. Junt, T. et al. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL. J. Immunol. 173, 6684-6693 (2004).
80. Scandella, E. et al. Dendritic cell-independent B cell activation during acute virus infection: a role for early CCR7-driven B-T helper cell collaboration. J. Immunol. 178, 1468-1476 (2007).
81. Mori, S. et al. Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J. Exp. Med. 193, 207-218 (2001).
82. Kursar, M. et al. Differential requirements for the chemokine receptor CCR7 in T cell activation during Listeria monocytogenes infection. J. Exp. Med. 201, 1447-1457 (2005).
83. Celli, S., Garcia, Z., Beuneu, H. & Bousso, P. Decoding the dynamics of T cell-dendritic cell interactions in vivo. Immunol. Rev. 221, 182-187 (2008).
84. + T-cell exit from the white pulp to the red pulp of the spleen through bridging channels.
85. Pape, K. A., Catron, D. M., Itano, A. A. & Jenkins, M. K. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 26, 491-502 (2007).
86. Lammermann, T. & Sixt, M. The microanatomy of T-cell responses. Immunol. Rev. 221, 26-43 (2008).
87. Amino, R. et al. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nature Med. 12, 220-224 (2006).
88. + dendritic cells but not by Langerhans cells. Science 301, 1925-1928 (2003).
89. Benedict, C. A. et al. Specific remodeling of splenic architecture by cytomegalovirus. PLoS Pathog. 2, e16 (2006).
90. Mueller, S. N. et al. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317, 670-674 (2007). This paper shows that viral infection can lead to the downregulation of constitutive chemokine expression, thereby precipitating a transient period of immunosuppression.
91. Scandella, E. et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nature Immunol. 9, 667-675 (2008). This study shows that the interaction between LTi cells and mesenchymal organizer cells can be reactivated following the infection-associated immunopathological destruction of SLO microenvironments.
92. Odermatt, B., Eppler, M., Leist, T. P., Hengartner, H. & Zinkernagel, R. M. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc. Natl Acad. Sci. USA 88, 8252-8256 (1991).
93. Heikenwalder, M. et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nature Med. 10, 187-192 (2004).
94. Yasuda, T. et al. Chemokines CCL19 and CCL21 promote activation-induced cell death of antigen-responding T cells. Blood 109, 449-456 (2007).
95. Pham, T. H., Okada, T., Matloubian, M., Lo, C. G. & Cyster, J. G. S1P1 receptor signaling overrides retention mediated by Gαi-coupled receptors to promote T cell egress. Immunity 28, 122-133 (2008).
96. Kaech, S. M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nature Immunol. 4, 1191-1198 (2003).
97. + T cells to HIV-1 infection: a novel model of HIV-1 latency. Blood 110, 4161-4164 (2007).
98. Ato, M., Stager, S., Engwerda, C. R. & Kaye, P. M. Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nature Immunol. 3, 1185-1191 (2002).
99. Mercer, J. A., Wiley, C. A. & Spector, D. H. Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J. Virol. 62, 987-997 (1988).
100. Bogdan, C. et al. Fibroblasts as host cells in latent leishmaniosis. J. Exp. Med. 191, 2121-2130 (2000).
101. Weiss, L. Mechanisms of splenic control of murine malaria: cellular reactions of the spleen in lethal (strain 17XL) Plasmodium yoelii malaria in BALB/c mice, and the consequences of pre-infective splenectomy. Am. J. Trop. Med. Hyg. 41, 144-160 (1989).
102. Macpherson, A. J. & Harris, N. L. Interactions between commensal intestinal bacteria and the immune system. Nature Rev. Immunol. 4, 478-485 (2004).
103. Macpherson, A. J. & Smith, K. Mesenteric lymph nodes at the center of immune anatomy. J. Exp. Med. 203, 497-500 (2006).
104. Siegrist, C. A. Neonatal and early life vaccinology. Vaccine 19, 3331-3346 (2001).
105. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O. & Kasper, D. L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118 (2005). This study shows that during colonization of germ-free animals with the ubiquitous gut microorganism B. fragilis, a bacterial cell-wall polysaccharide is sufficient to direct the cellular and morphological maturation of the immune system.
106. Ngo, V. N., Cornall, R. J. & Cyster, J. G. Splenic T zone development is B cell dependent. J. Exp. Med. 194, 1649-1660 (2001).
107. Mazzucchelli, L. et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J. Clin. Invest. 104, R49-R54 (1999).
108. Ghosh, S., Steere, A. C., Stollar, B. D. & Huber, B. T. In situ diversification of the antibody repertoire in chronic Lyme arthritis synovium. J. Immunol. 174, 2860-2869 (2005).
109. Browning, J. L. Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease. Immunol. Rev. 223, 202-220 (2008).
110. Zheng, H. et al. How antigen quantity and quality determine T-cell decisions in lymphoid tissue. Mol. Cell Biol. 28, 4040-4051 (2008).
111. Zinkernagel, R. M. et al. Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol. Rev. 156, 199-209 (1997).
112. Mebius, R. E. Organogenesis of lymphoid tissues. Nature Rev. Immunol. 3, 292-303 (2003).
113. Drayton, D. L., Liao, S., Mounzer, R. H. & Ruddle, N. H. Lymphoid organ development: from ontogeny to neogenesis. Nature Immunol. 7, 344-353 (2006).
114. 1 integrin activation by CXCR5. Immunity 17, 363-373 (2002).
115. Tumanov, A. et al. Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity 17, 239-250 (2002).